We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. There are…
Read More
Study dives into genetic risk of Alzheimer’s and dementia for diverse Latinx groups
Alzheimer’s disease and related dementias (ADRD) are degenerative brain diseases that affect over 5.8 million people in the U.S. Rates of ADRD are higher among…
Read More
Molecular alterations in neuronal trophic regulation in Alzheimer’s pathology
For decades researchers have known that Alzheimer’s disease (AD) causes the atrophy of a system of neurons and synapses highly involved in memory, learning and…
Read More
Dementia: Do your gums look like this? It could increase risk of progressive condition
Dementia is the name given to a group of symptoms linked to an ongoing decline in brain function. Scientists have now discovered a possible link…
Read More
Study finds path for addressing Alzheimer’s blood-brain barrier impairment
By developing a lab-engineered model of the human blood-brain barrier (BBB), neuroscientists at MIT’s Picower Institute for Learning and Memory have discovered how the most…
Read More
Antibody designed to recognize pathogens of Alzheimer’s disease
Researchers have found a way to design an antibody that can identify the toxic particles that destroy healthy brain cells—a potential advance in the fight…
Read More
Dementia: An easier and cheaper test performed at your GP could mean early diagnosis
Symptoms of dementia in the later stages include problems with memory, concentration, planning, mobility and experiencing changes in behaviour. The condition is said to be…
Read More
Drugs fail to slow decline in inherited Alzheimer’s disease
Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer’s disease at a…
Read More
Teams publish in vivo Alzheimer’s disease treatment data
Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer’s disease (AD) and related neurodegenerative disorders, and the Feinstein Institutes…
Read More
Retinal imaging technology for early detection of Alzheimer’s disease
Alzheimer’s disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050. Damage…
Read More